JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vahlensieck, U.
Right arrow Articles by Schmitz, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vahlensieck, U.
Right arrow Articles by Schmitz, W.

Vol. 288, Issue 2, 805-813, February 1999

Inotropic Effects of Diadenosine Tetraphosphate (AP4A) in Human and Animal Cardiac Preparations

U. Vahlensieck, P. Bokník, I. Gombosová, S. Huke, J. Knapp, B. Linck, H. Lübeta , F. U. Müller, J. Neumann, M. C. Deng1, H. H. Scheld1, H. Jankowski2, H. Schlüter2, W. Zidek2, N. Zimmermann3 and W. Schmitz

Institut für Pharmakologie und Toxikologie, Westfälische Wilhelms-Universität Münster, Germany

Diadenosine tetraphosphate (AP4A) is an endogenous compound and exerts diverse physiological effects in animal systems. However, the effects of AP4A on inotropy in ventricular cardiac preparations have not yet been studied. The effects of AP4A on force of contraction (FOC) were studied in isolated electrically driven guinea pig and human cardiac preparations. Furthermore, the effects of AP4A on L-type calcium current and [Ca]i were studied in isolated guinea pig ventricular myocytes. In guinea pig left atria, AP4A (0.1-100 µM) reduced FOC maximally by 36.5 ± 4.3%. In guinea pig papillary muscles, AP4A (100 µM) alone was ineffective, but reduced isoproterenol-stimulated FOC maximally by 29.3 ± 3.4%. The negative inotropic effects of AP4A in atria and papillary muscles were abolished by the A1-adenosine receptor antagonist 1,3-dipropyl-cyclopentylxanthine. In guinea pig ventricular myocytes, AP4A (100 µM) attenuated isoproterenol-stimulated L-type calcium current and [Ca]i. In human atrial and ventricular preparations, AP4A (100 µM) alone increased FOC to 158.3 ± 12.4% and 167.5 ± 25.1%, respectively. These positive inotropic effects were abolished by the P2-purinoceptor antagonist suramin. On the other hand, AP4A (100 µM) reduced FOC by 27.2 ± 7.4% in isoproterenol-stimulated human ventricular trabeculae. The latter effect was abolished by 1,3-dipropyl-cyclopentylxanthine. In summary, after beta adrenergic stimulation AP4A exerts negative inotropic effects in animal and human ventricular preparations via stimulation of A1-adenosine receptors. In contrast, AP4A alone can exert positive inotropic effects via P2-purinoceptors in human ventricular myocardium. Thus, P2-purinoceptor stimulation might be a new positive inotropic principle in the human myocardium.


0022-3565/99/2882-0805$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. L. Garcia-Villalon, L. Monge, N. Fernandez, A. Salcedo, R. Narvaez-Sanchez, and G. Dieguez
Coronary response to diadenosine pentaphosphate after ischaemia-reperfusion in the isolated rat heart
Cardiovasc Res, February 1, 2009; 81(2): 336 - 343.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
U. Gergs, P. Boknik, W. Schmitz, A. Simm, R.-E. Silber, and J. Neumann
A positive inotropic effect of ATP in the human cardiac atrium
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1716 - H1723.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Luo, V. Jankowski, N. Gungar, J. Neumann, W. Schmitz, W. Zidek, H. Schluter, and J. Jankowski
Endogenous Diadenosine Tetraphosphate, Diadenosine Pentaphosphate, and Diadenosine Hexaphosphate in Human Myocardial Tissue
Hypertension, May 1, 2004; 43(5): 1055 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Vassort
Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium
Physiol Rev, April 1, 2001; 81(2): 767 - 806.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.